Northwestern Medicine’s Dr. Sonabend explains Sen. John McCain’s battle with glioblastoma

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

WASHINGTON, DC - APRIL 07: Sen. John McCain (R-AZ) answers questions at the U.S. Capitol about the recent U.S. attack in Syria April 7, 2017 in Washington, DC. U.S. President Donald Trump ordered a retaliatory strike yesterday in response to the use of chemical weapons by the government of Syrian President Bashar al-Assad. (Photo by Win McNamee/Getty Images)

Assistant Professor of Neurological Surgery at Northwestern Medicine, Dr. Adam Sonabend joins Roe Conn & Anna Davlantes to discuss Sen. John McCain’s announcement to discontinue his medical treatments for glioblastoma. Dr. Sonabend’s clinical focus is on the surgical of management of tumors of the brain and skull base, including brain metastasis from other cancers, intraventricular tumors, gliomas such as glioblastomas.

Follow your favorite Roe Conn Show characters on Twitter

And be sure to follow Roe on Facebook!

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.